{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:32:47Z","timestamp":1780320767964,"version":"3.54.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side effects, including an increased risk of infections. Via both mechanism, immune impairments and cardiometabolic concomitant diseases, patients with GC excess could be at increased risk for COVID-19. The impact on incidence and outcome of a SARS-CoV-2 infection in this population are not yet completely clear. This review aims to compile the data available to date and to discuss the existing literature on this topic. Further we highlight potential effects of SARS-CoV-2 on the hypothalamic-pituitary-adrenal axis as well as the influence of endogenous or exogenous GC excess on SARS-CoV-2 mRNA vaccination. There is growing evidence suggesting an increased risk of infection and severe outcome in patients with high-dose GC therapy after contracting SARS-CoV-2. The few data and case reports on patients with endogenous GC excess and SARS-CoV-2 infection point in a similar direction: chronic GC excess seems to be associated with an unfavorable course of COVID-19. Whether this is mainly a primary immune-mediated effect, or also triggered by the many GC-associated comorbidities in this population, is not yet fully understood. Patients with endogenous or exogenous GC excess should be considered as a vulnerable group during the SARS-CoV-2 pandemic. Regardless of the cause, vaccination and consistent surveillance and control of associated comorbidities are recommended.<\/jats:p>","DOI":"10.1007\/s11154-021-09670-0","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:03:31Z","timestamp":1625814211000},"page":"233-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-8968","authenticated-orcid":false,"given":"Frederick","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"9670_CR1","doi-asserted-by":"crossref","unstructured":"Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol. 2021.","DOI":"10.1038\/s41577-021-00522-1"},{"issue":"10229","key":"9670_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet."},{"issue":"18","key":"9670_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med."},{"issue":"7","key":"9670_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jmv.25783","volume":"92","author":"S Wan","year":"2020","unstructured":"Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797\u2013806.","journal-title":"J Med Virol."},{"issue":"7","key":"9670_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","volume":"5","author":"M Madjid","year":"2020","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5(7):831\u201340.","journal-title":"JAMA Cardiol."},{"issue":"4","key":"9670_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10238-020-00648-x","volume":"20","author":"M Gavriatopoulou","year":"2020","unstructured":"Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20(4):493\u2013506.","journal-title":"Clin Exp Med."},{"issue":"10223","key":"9670_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet."},{"key":"9670_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fmed.2020.00532","volume":"7","author":"L Zou","year":"2020","unstructured":"Zou L, Dai L, Zhang Y, Fu W, Gao Y, Zhang Z, et al. Clinical Characteristics and Risk Factors for Disease Severity and Death in Patients With Coronavirus Disease 2019 in Wuhan, China. Front Med (Lausanne). 2020;7:532.","journal-title":"Front Med (Lausanne)."},{"key":"9670_CR9","doi-asserted-by":"crossref","unstructured":"Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM, et al. Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis. Rev Endocr Metab Disord. 2021.","DOI":"10.1007\/s11154-021-09630-8"},{"key":"9670_CR10","doi-asserted-by":"crossref","unstructured":"Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97\u20139.","DOI":"10.1016\/j.ejim.2020.04.043"},{"key":"9670_CR11","doi-asserted-by":"crossref","unstructured":"Nissen CB, Sciascia S, de Andrade D, Atsumi T, Bruce IN, Cron RQ, et al. The role of antirheumatics in patients with COVID-19. Lancet Rheumatol. 2021.","DOI":"10.1016\/S2665-9913(21)00062-X"},{"issue":"8","key":"9670_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Group RC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med."},{"issue":"10","key":"9670_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","volume":"141","author":"L Wei","year":"2004","unstructured":"Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141(10):764\u201370.","journal-title":"Ann Intern Med."},{"key":"9670_CR14","doi-asserted-by":"crossref","unstructured":"Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study. BMJ. 2012;345:e4928.","DOI":"10.1136\/bmj.e4928"},{"issue":"1","key":"9670_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","volume":"157","author":"L Fardet","year":"2007","unstructured":"Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol. 2007;157(1):142\u20138.","journal-title":"Br J Dermatol."},{"issue":"Suppl 1","key":"9670_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314297","volume":"92","author":"C Steffensen","year":"2010","unstructured":"Steffensen C, Bak AM, Rubeck KZ, Jorgensen JO. Epidemiology of Cushing\u2019s syndrome. Neuroendocrinology. 2010;92(Suppl 1):1\u20135.","journal-title":"Neuroendocrinology."},{"issue":"24","key":"9670_CR17","doi-asserted-by":"publisher","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","volume":"111","author":"SA Morgan","year":"2014","unstructured":"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, et al. 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A. 2014;111(24):E2482-91.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"9670_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","volume":"93","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93(2):105\u201311.","journal-title":"QJM."},{"issue":"2","key":"9670_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr.21796","volume":"65","author":"RA Overman","year":"2013","unstructured":"Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013;65(2):294\u20138.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"4","key":"9670_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2213-8587(20)30040-1","volume":"8","author":"M Reincke","year":"2020","unstructured":"Reincke M. Metformin: the white knight fighting corticosteroid side-effects. Lancet Diabetes Endocrinol. 2020;8(4):258\u20139.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"9670_CR21","doi-asserted-by":"crossref","unstructured":"Fareau GG, Vassilopoulou-Sellin R. Hypercortisolemia and infection. Infect Dis Clin North Am. 2007;21(3):639\u201357, viii.","DOI":"10.1016\/j.idc.2007.06.001"},{"issue":"12","key":"9670_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.revmed.2007.05.030","volume":"28","author":"H Dussauze","year":"2007","unstructured":"Dussauze H, Bourgault I, Doleris LM, Prinseau J, Baglin A, Hanslik T. Systemic corticosteroid treatment and risk of infectious diseases. Rev Med Interne. 2007;28(12):841\u201351.","journal-title":"Rev Med Interne."},{"issue":"9398","key":"9670_CR23","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","volume":"362","author":"MS Lionakis","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362(9398):1828\u201338.","journal-title":"Lancet."},{"issue":"1","key":"9670_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2\u201313.","journal-title":"Mol Cell Endocrinol."},{"issue":"7","key":"9670_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012;71(7):1128\u201333.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"9670_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13075-020-02395-6","volume":"22","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Bugatti S, Klersy C, Biggioggero M, Rossi S, De Lucia O, et al. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther. 2020;22(1):290.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"9670_CR27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4049\/jimmunol.179.1.578","volume":"179","author":"N Zhang","year":"2007","unstructured":"Zhang N, Truong-Tran QA, Tancowny B, Harris KE, Schleimer RP. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT\/enhancer binding proteins. J Immunol. 2007;179(1):578\u201389.","journal-title":"J Immunol."},{"key":"9670_CR28","doi-asserted-by":"crossref","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020.","DOI":"10.1136\/annrheumdis-2021-219918"},{"key":"9670_CR29","doi-asserted-by":"crossref","unstructured":"Fitzgerald KC, Mecoli CA, Douglas M, Harris S, Aravidis B, Albayda J, et al. Risk Factors for Infection and Health Impacts of the Covid-19 Pandemic in People with Autoimmune Diseases. medRxiv. 2021.","DOI":"10.1101\/2021.02.03.21251069"},{"key":"9670_CR30","doi-asserted-by":"crossref","unstructured":"Soldevila-Domenech N, Tio L, Llorente-Onaindia J, Martin-Garcia E, Nebot P, de la Torre R, et al. COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments. Front Pharmacol. 2020;11:583260.","DOI":"10.3389\/fphar.2020.583260"},{"issue":"7","key":"9670_CR31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859\u201366.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"9670_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","volume":"383","author":"R Haberman","year":"2020","unstructured":"Haberman R, Axelrad J, Chen A, Castillo R, Yan D, Izmirly P, et al. Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. N Engl J Med. 2020;383(1):85\u20138.","journal-title":"N Engl J Med."},{"issue":"12","key":"9670_CR33","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.41456","volume":"72","author":"RH Haberman","year":"2020","unstructured":"Haberman RH, Castillo R, Chen A, Yan D, Ramirez D, Sekar V, et al. COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes. Arthritis Rheumatol. 2020;72(12):1981\u20139.","journal-title":"Arthritis Rheumatol."},{"key":"9670_CR34","doi-asserted-by":"crossref","unstructured":"Arleo T, Tong D, Shabto J, O'Keefe G, Khosroshahi A. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population. Clin Rheumatol. 2021.","DOI":"10.1007\/s10067-021-05578-x"},{"key":"9670_CR35","doi-asserted-by":"crossref","unstructured":"Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, et al. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 2021;7(1).","DOI":"10.1136\/rmdopen-2020-001464"},{"key":"9670_CR36","doi-asserted-by":"crossref","unstructured":"Fredi M, Cavazzana I, Moschetti L, Andreoli L, Franceschini F, Brescia Rheumatology C-SG. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study. Lancet Rheumatol. 2020;2(9):e549\u2013e56.","DOI":"10.1016\/S2665-9913(20)30169-7"},{"issue":"11","key":"9670_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2020-217984","volume":"79","author":"DD Freites Nunez","year":"2020","unstructured":"Freites Nunez DD, Leon L, Mucientes A, Rodriguez-Rodriguez L, Font Urgelles J, Madrid Garcia A, et al. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(11):1393\u20139.","journal-title":"Ann Rheum Dis."},{"key":"9670_CR38","doi-asserted-by":"crossref","unstructured":"Cordtz R, Lindhardsen J, Soussi BG, Vela J, Uhrenholt L, Westermann R, et al. Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark. Rheumatology (Oxford). 2020.","DOI":"10.1093\/rheumatology\/keaa897"},{"key":"9670_CR39","doi-asserted-by":"crossref","unstructured":"Grainger R, Machado PM, Robinson PC. Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes. Best Pract Res Clin Rheumatol. 2020:101657.","DOI":"10.1016\/j.berh.2020.101657"},{"key":"9670_CR40","doi-asserted-by":"crossref","unstructured":"Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020;159(2):481\u201391 e3.","DOI":"10.1053\/j.gastro.2020.05.032"},{"key":"9670_CR41","doi-asserted-by":"crossref","unstructured":"Strangfeld A, Schafer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021.","DOI":"10.1136\/annrheumdis-2021-220134"},{"key":"9670_CR42","doi-asserted-by":"crossref","unstructured":"Rutherford MA, Scott J, Karabayas M, Antonelou M, Gopaluni S, Gray D, et al. Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study. Arthritis Rheumatol. 2021.","DOI":"10.1002\/art.41728"},{"issue":"12","key":"9670_CR43","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L, Lledo A, Retuerto M, Blanco R, et al. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 2020;79(12):1544\u20139.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"9670_CR44","first-page":"82","volume":"2","author":"C Ye","year":"2021","unstructured":"Ye C, Zhong J, Cai S, Dong L, Li C, Hou X, et al. COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province. China MedComm (Beijing). 2021;2(1):82\u201390.","journal-title":"China. MedComm (Beijing)"},{"issue":"8","key":"9670_CR45","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S2213-8587(20)30215-1","volume":"8","author":"R Pivonello","year":"2020","unstructured":"Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A. COVID-19 and Cushing\u2019s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020;8(8):654\u20136.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"9670_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233\u201347.","journal-title":"Nat Rev Immunol."},{"issue":"9","key":"9670_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","volume":"31","author":"V Hasenmajer","year":"2020","unstructured":"Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The Immune System in Cushing\u2019s Syndrome. Trends Endocrinol Metab. 2020;31(9):655\u201369.","journal-title":"Trends Endocrinol Metab."},{"key":"9670_CR48","doi-asserted-by":"crossref","unstructured":"Belaya Z, Golounina O, Melnichenko G, Tarbaeva N, Pashkova E, Gorokhov M, et al. Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations. Endocrine. 2021.","DOI":"10.1007\/s12020-021-02674-5"},{"key":"9670_CR49","doi-asserted-by":"crossref","unstructured":"Serban AL, Ferrante E, Carosi G, Indirli R, Arosio M, Mantovani G. COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy. J Endocrinol Invest. 2020.","DOI":"10.1007\/s40618-020-01419-x"},{"key":"9670_CR50","doi-asserted-by":"crossref","unstructured":"Yuno A, Kenmotsu Y, Takahashi Y, Nomoto H, Kameda H, Cho KY, et al. Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. Endocr J. 2020.","DOI":"10.1507\/endocrj.EJ20-0613"},{"issue":"8","key":"9670_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","volume":"8","author":"T Tan","year":"2020","unstructured":"Tan T, Khoo B, Mills EG, Phylactou M, Patel B, Eng PC, et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8(8):659\u201360.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"9670_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.32598\/bcn.11.covid19.1168.2","volume":"11","author":"M Ramezani","year":"2020","unstructured":"Ramezani M, Simani L, Karimialavijeh E, Rezaei O, Hajiesmaeili M, Pakdaman H. The Role of Anxiety and Cortisol in Outcomes of Patients With Covid-19. Basic Clin Neurosci. 2020;11(2):179\u201384.","journal-title":"Basic Clin Neurosci."},{"issue":"3","key":"9670_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/clinem\/dgaa874","volume":"106","author":"C Edwards","year":"2021","unstructured":"Edwards C. New Horizons: Does Mineralocorticoid Receptor Activation by Cortisol Cause ATP Release and COVID-19 Complications? J Clin Endocrinol Metab. 2021;106(3):622\u201335.","journal-title":"J Clin Endocrinol Metab."},{"key":"9670_CR54","doi-asserted-by":"crossref","unstructured":"Funder JW. Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology. Int J Mol Sci. 2017;18(5).","DOI":"10.3390\/ijms18051032"},{"issue":"3","key":"9670_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376.","journal-title":"Lancet Respir Med."},{"key":"9670_CR56","doi-asserted-by":"crossref","unstructured":"Karan A, Ali K, Rambaran K, Del Corral P, Sakhamuri S, Teelucksingh S. COVID-19 and ethnicity: Does reduced responsiveness to glucocorticoids explain the more aggressive nature of disease among minorities? Med Hypotheses. 2020;144:110220.","DOI":"10.1016\/j.mehy.2020.110220"},{"key":"9670_CR57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1196\/annals.1321.014","volume":"1024","author":"E Charmandari","year":"2004","unstructured":"Charmandari E, Kino T, Chrousos GP. Familial\/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci. 2004;1024:168\u201381.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"9670_CR58","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-20-0352","volume":"183","author":"J Newell-Price","year":"2020","unstructured":"Newell-Price J, Nieman LK, Reincke M, Tabarin A. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing\u2019s syndrome. Eur J Endocrinol. 2020;183(1):G1\u20137.","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"9670_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11102-020-01059-7","volume":"23","author":"M Fleseriu","year":"2020","unstructured":"Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, et al. Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary. 2020;23(4):327\u201337.","journal-title":"Pituitary."},{"issue":"8","key":"9670_CR60","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4158\/EP-2020-0308","volume":"26","author":"KCJ Yuen","year":"2020","unstructured":"Yuen KCJ, Blevins LS Jr, Findling JW. Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic. Endocr Pract. 2020;26(8):915\u201322.","journal-title":"Endocr Pract."},{"key":"9670_CR61","doi-asserted-by":"crossref","unstructured":"Guarnotta V, Ferrigno R, Martino M, Barbot M, Isidori AM, Scaroni C, et al. Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord. 2020.","DOI":"10.1007\/s11154-020-09598-x"},{"issue":"6","key":"9670_CR62","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u201340.","journal-title":"Lancet Haematol."},{"key":"9670_CR63","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fendo.2018.00805","volume":"9","author":"J Wagner","year":"2018","unstructured":"Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing\u2019s Syndrome: A Systematic Meta-Analysis. Front Endocrinol (Lausanne). 2018;9:805.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"9670_CR64","doi-asserted-by":"crossref","unstructured":"St-Jean M, Lim DST, Langlois F. Hypercoagulability in Cushing's syndrome: From arterial to venous disease. Best Pract Res Clin Endocrinol Metab. 2021:101496.","DOI":"10.1016\/j.beem.2021.101496"},{"key":"9670_CR65","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fendo.2020.00554","volume":"11","author":"F Beretta","year":"2020","unstructured":"Beretta F, Dassie F, Parolin M, Boscari F, Barbot M, Busetto L, et al. Practical Considerations for the Management of Cushing\u2019s Disease and COVID-19: A Case Report. Front Endocrinol (Lausanne). 2020;11:554.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"10223","key":"9670_CR66","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506.","journal-title":"China. Lancet."},{"key":"9670_CR67","doi-asserted-by":"crossref","unstructured":"Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020;12(4):e7560.","DOI":"10.7759\/cureus.7560"},{"issue":"Suppl 1","key":"9670_CR68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000318566","volume":"92","author":"M De Leo","year":"2010","unstructured":"De Leo M, Pivonello R, Auriemma RS, Cozzolino A, Vitale P, Simeoli C, et al. Cardiovascular disease in Cushing\u2019s syndrome: heart versus vasculature. Neuroendocrinology. 2010;92(Suppl 1):50\u20134.","journal-title":"Neuroendocrinology."},{"issue":"1","key":"9670_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"AM Isidori","year":"2015","unstructured":"Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, et al. The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens. 2015;33(1):44\u201360.","journal-title":"J Hypertens."},{"issue":"4","key":"9670_CR70","doi-asserted-by":"publisher","first-page":"M133","DOI":"10.1530\/EJE-15-0354","volume":"173","author":"F Ferrau","year":"2015","unstructured":"Ferrau F, Korbonits M. Metabolic comorbidities in Cushing\u2019s syndrome. Eur J Endocrinol. 2015;173(4):M133-57.","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"9670_CR71","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"Ragnarsson O, Olsson DS, Papakokkinou E, Chantzichristos D, Dahlqvist P, Segerstedt E, et al. Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study. J Clin Endocrinol Metab. 2019;104(6):2375\u201384.","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"9670_CR72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611\u201329.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"9670_CR73","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","volume":"4","author":"RN Clayton","year":"2016","unstructured":"Clayton RN, Jones PW, Reulen RC, Stewart PM, Hassan-Smith ZK, Ntali G, et al. Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 2016;4(7):569\u201376.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"9670_CR74","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, et al. Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab. 1999;84(8):2664\u201372.","journal-title":"J Clin Endocrinol Metab."},{"key":"9670_CR75","doi-asserted-by":"crossref","unstructured":"Vogel F, Braun LT, Rubinstein G, Zopp S, Kunzel H, Strasding F, et al. Persisting muscle dysfunction in Cushing's syndrome despite biochemical remission. J Clin Endocrinol Metab. 2020.","DOI":"10.1210\/clinem\/dgaa625"},{"issue":"9","key":"9670_CR76","doi-asserted-by":"publisher","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","volume":"97","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, Berglund P, Eder DN, Johannsson G. Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission. J Clin Endocrinol Metab. 2012;97(9):E1640-8.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"9670_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-14-0747","volume":"172","author":"O Ragnarsson","year":"2015","unstructured":"Ragnarsson O, Glad CA, Bergthorsdottir R, Almqvist EG, Ekerstad E, Widell H, et al. Body composition and bone mineral density in women with Cushing\u2019s syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity. Eur J Endocrinol. 2015;172(1):1\u201310.","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"9670_CR78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4158\/EP12247.OR","volume":"19","author":"AL Espinosa-de-Los-Monteros","year":"2013","unstructured":"Espinosa-de-Los-Monteros AL, Sosa E, Martinez N, Mercado M. Persistence of Cushing\u2019s disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation. Endocr Pract. 2013;19(2):252\u20138.","journal-title":"Endocr Pract."},{"key":"9670_CR79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jsbmb.2019.04.006","volume":"190","author":"I Berger","year":"2019","unstructured":"Berger I, Werdermann M, Bornstein SR, Steenblock C. The adrenal gland in stress - Adaptation on a cellular level. J Steroid Biochem Mol Biol. 2019;190:198\u2013206.","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"1","key":"9670_CR80","first-page":"55","volume":"21","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55\u201389.","journal-title":"Endocr Rev."},{"key":"9670_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mce.2014.11.012","volume":"408","author":"B Peeters","year":"2015","unstructured":"Peeters B, Boonen E, Langouche L, Van den Berghe G. The HPA axis response to critical illness: New study results with diagnostic and therapeutic implications. Mol Cell Endocrinol. 2015;408:235\u201340.","journal-title":"Mol Cell Endocrinol."},{"key":"9670_CR82","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","DOI":"10.1002\/path.1570"},{"key":"9670_CR83","doi-asserted-by":"crossref","unstructured":"Mao Y, Xu B, Guan W, Xu D, Li F, Ren R, et al. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection. Front Endocrinol (Lausanne). 2020;11:593179.","DOI":"10.3389\/fendo.2020.593179"},{"issue":"2","key":"9670_CR84","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12020-020-02325-1","volume":"68","author":"R Pal","year":"2020","unstructured":"Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. 2020;68(2):251\u20132.","journal-title":"Endocrine."},{"issue":"2","key":"9670_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.eprac.2020.10.014","volume":"27","author":"AS Alzahrani","year":"2021","unstructured":"Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, et al. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocr Pract. 2021;27(2):83\u20139.","journal-title":"Endocr Pract."},{"issue":"4","key":"9670_CR86","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.4269\/ajtmh.20-0787","volume":"103","author":"M Freire Santana","year":"2020","unstructured":"Santana MF, Borba MGS, Baia-da-Silva DC, Val F, Alexandre MAA, Brito-Sousa JD, et al. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study. Am J Trop Med Hyg. 2020;103(4):1604\u20137.","journal-title":"Am J Trop Med Hyg."},{"issue":"6","key":"9670_CR87","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","volume":"1","author":"B Hanley","year":"2020","unstructured":"Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245\u201353.","journal-title":"Lancet Microbe."},{"issue":"5","key":"9670_CR88","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.mehy.2004.04.009","volume":"63","author":"R Wheatland","year":"2004","unstructured":"Wheatland R. Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis. Med Hypotheses. 2004;63(5):855\u201362.","journal-title":"Med Hypotheses."},{"issue":"2","key":"9670_CR89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","volume":"63","author":"MK Leow","year":"2005","unstructured":"Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). 2005;63(2):197\u2013202.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"9670_CR90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fmed.2020.00170","volume":"7","author":"N Veronese","year":"2020","unstructured":"Veronese N, Demurtas J, Yang L, Tonelli R, Barbagallo M, Lopalco P, et al. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature. Front Med (Lausanne). 2020;7:170.","journal-title":"Front Med (Lausanne)."},{"key":"9670_CR91","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","volume":"10","author":"C Strehl","year":"2019","unstructured":"Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System. Front Immunol. 2019;10:1744.","journal-title":"Front Immunol."},{"issue":"2","key":"9670_CR92","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/en.2013-1473","volume":"155","author":"AL Gruver-Yates","year":"2014","unstructured":"Gruver-Yates AL, Quinn MA, Cidlowski JA. Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development. Endocrinology. 2014;155(2):463\u201374.","journal-title":"Endocrinology."},{"issue":"1","key":"9670_CR93","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1081-1206(10)61380-4","volume":"97","author":"ME Fedor","year":"2006","unstructured":"Fedor ME, Rubinstein A. Effects of long-term low-dose corticosteroid therapy on humoral immunity. Ann Allergy Asthma Immunol. 2006;97(1):113\u20136.","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"3","key":"9670_CR94","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1634\/theoncologist.2011-0342","volume":"17","author":"AF Hottinger","year":"2012","unstructured":"Hottinger AF, George AC, Bel M, Favet L, Combescure C, Meier S, et al. A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A\/H1N1 vaccine in cancer outpatients. Oncologist. 2012;17(3):436\u201345.","journal-title":"Oncologist."},{"key":"9670_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13075-015-0663-9","volume":"17","author":"L Fischer","year":"2015","unstructured":"Fischer L, Gerstel PF, Poncet A, Siegrist CA, Laffitte E, Gabay C, et al. Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases\u2013a longitudinal study. Arthritis Res Ther. 2015;17:151.","journal-title":"Arthritis Res Ther."},{"issue":"33","key":"9670_CR96","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Yildiz","year":"2013","unstructured":"Yildiz N, Sever L, Kasapcopur O, Cullu F, Arisoy N, Caliskan S. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine. 2013;31(33):3309\u201312.","journal-title":"Vaccine."},{"issue":"1","key":"9670_CR97","first-page":"53","volume":"242","author":"A Herron","year":"1979","unstructured":"Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy JAMA. 1979;242(1):53\u20136.","journal-title":"Safety and efficacy. JAMA."},{"issue":"2","key":"9670_CR98","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1378\/chest.110.2.367","volume":"110","author":"MA Kubiet","year":"1996","unstructured":"Kubiet MA, Gonzalez-Rothi RJ, Cottey R, Bender BS. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest. 1996;110(2):367\u201370.","journal-title":"Chest."},{"issue":"7","key":"9670_CR99","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/acr.20465","volume":"63","author":"O Elkayam","year":"2011","unstructured":"Elkayam O, Amir S, Mendelson E, Schwaber M, Grotto I, Wollman J, et al. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken). 2011;63(7):1062\u20137.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"9670_CR100","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2147\/JPR.S302115","volume":"14","author":"K Chakravarthy","year":"2021","unstructured":"Chakravarthy K, Strand N, Frosch A, Sayed D, Narra LR, Chaturvedi R, et al. Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2021;14:623\u20139.","journal-title":"J Pain Res."},{"issue":"2","key":"9670_CR101","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mayocpiqo.2018.01.005","volume":"2","author":"TT Sytsma","year":"2018","unstructured":"Sytsma TT, Greenlund LK, Greenlund LS. Joint Corticosteroid Injection Associated With Increased Influenza Risk. Mayo Clin Proc Innov Qual Outcomes. 2018;2(2):194\u20138.","journal-title":"Mayo Clin Proc Innov Qual Outcomes."},{"issue":"8","key":"9670_CR102","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/pm\/pnaa199","volume":"21","author":"DC Miller","year":"2020","unstructured":"Miller DC, Patel J, Gill J, Mattie R, Saffarian M, Schneider BJ, et al. Corticosteroid Injections and COVID-19 Infection Risk. Pain Med. 2020;21(8):1703\u20136.","journal-title":"Pain Med."},{"key":"9670_CR103","doi-asserted-by":"crossref","unstructured":"Lee H, Punt JA, Miller DC, Nagpal A, Smith CC, Sayeed Y, et al. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of mRNA COVID-19 Vaccines? Pain Med. 2021.","DOI":"10.1093\/pm\/pnab063"},{"issue":"2 Pt 1","key":"9670_CR104","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1542\/peds.98.2.196","volume":"98","author":"CL Park","year":"1996","unstructured":"Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics. 1996;98(2 Pt 1):196\u2013200.","journal-title":"Pediatrics."},{"issue":"12","key":"9670_CR105","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/archpedi.152.12.1191","volume":"152","author":"MP Fairchok","year":"1998","unstructured":"Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med. 1998;152(12):1191\u20135.","journal-title":"Arch Pediatr Adolesc Med."},{"key":"9670_CR106","doi-asserted-by":"crossref","unstructured":"Bergmann M, Freisl M, Hartmann K, Speck S, Truyen U, Zablotski Y, et al. Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane. Vaccines (Basel). 2020;8(3).","DOI":"10.3390\/vaccines8030547"},{"key":"9670_CR107","doi-asserted-by":"crossref","unstructured":"Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021.","DOI":"10.1001\/jama.2021.4385"},{"issue":"20","key":"9670_CR108","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020;383(20):1920\u201331.","journal-title":"N Engl J Med."},{"issue":"25","key":"9670_CR109","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","volume":"383","author":"EE Walsh","year":"2020","unstructured":"Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020;383(25):2439\u201350.","journal-title":"N Engl J Med."},{"key":"9670_CR110","unstructured":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep. 1993;42(RR-4):1\u201318."},{"key":"9670_CR111","unstructured":"National Center for I, Respiratory D. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(2):1\u201364."},{"key":"9670_CR112","doi-asserted-by":"crossref","unstructured":"Schulze-Koops H, Specker C, Skapenko A. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open. 2021;7(1).","DOI":"10.1136\/rmdopen-2020-001553"},{"issue":"10","key":"9670_CR113","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S2468-1253(20)30269-7","volume":"5","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. IBD in the COVID-19 era: the value of international collaboration. Lancet Gastroenterol Hepatol. 2020;5(10):887\u20138.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"9670_CR114","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fendo.2019.00766","volume":"10","author":"LT Braun","year":"2019","unstructured":"Braun LT, Riester A, Osswald-Kopp A, Fazel J, Rubinstein G, Bidlingmaier M, et al. Toward a Diagnostic Score in Cushing\u2019s Syndrome. Front Endocrinol (Lausanne). 2019;10:766.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"9670_CR115","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/EJE-16-0815","volume":"176","author":"F Gokosmanoglu","year":"2017","unstructured":"Gokosmanoglu F, Guzel A, Kan EK, Atmaca H. Increased prevalence of obstructive sleep apnea in patients with Cushing\u2019s syndrome compared with weight- and age-matched controls. Eur J Endocrinol. 2017;176(3):267\u201372.","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"9670_CR116","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan. China JAMA Intern Med. 2020;180(7):934\u201343.","journal-title":"China. JAMA Intern Med."},{"issue":"2","key":"9670_CR117","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cen.13512","volume":"88","author":"DA Delivanis","year":"2018","unstructured":"Delivanis DA, Iniguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, et al. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018;88(2):209\u201316.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"9670_CR118","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/EJE-20-0541","volume":"183","author":"M Rottoli","year":"2020","unstructured":"Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, Giannella M, et al. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol. 2020;183(4):389\u201397.","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"9670_CR119","first-page":"307","volume":"39","author":"MR De Giorgio","year":"2020","unstructured":"De Giorgio MR, Di Noia S, Morciano C, Conte D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 2020;39(4):307\u201312.","journal-title":"Acta Myol."},{"issue":"5","key":"9670_CR120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1055\/a-0879-5122","volume":"51","author":"A Dhingra","year":"2019","unstructured":"Dhingra A, Ganie MA, Dharmshaktu P, Chakraborty S, Jyotsna VP, Gupta N. Pattern of Lipid Abnormalities Among South Asian Indians With Cushing\u2019s Syndrome and the Short Term Impact of Surgical Correction of Hypercortisolism. Horm Metab Res. 2019;51(5):309\u201314.","journal-title":"Horm Metab Res."},{"key":"9670_CR121","doi-asserted-by":"crossref","unstructured":"Zuin M, Rigatelli G, Bilato C, Cervellati C, Zuliani G, Roncon L. Dyslipidaemia and mortality in COVID-19 patients - a meta-analysis. QJM. 2021.","DOI":"10.1093\/qjmed\/hcab071"},{"key":"9670_CR122","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2015.00129","volume":"9","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, Simeoli C, De Martino MC, Cozzolino A, De Leo M, Iacuaniello D, et al. Neuropsychiatric disorders in Cushing\u2019s syndrome. Front Neurosci. 2015;9:129.","journal-title":"Front Neurosci."},{"key":"9670_CR123","doi-asserted-by":"crossref","unstructured":"Barcella CA, Polcwiartek C, Mohr GH, Hodges G, Sondergaard K, Bang C, et al. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr Scand. 2021.","DOI":"10.1111\/acps.13309"},{"key":"9670_CR124","doi-asserted-by":"crossref","unstructured":"Strausz S, Kiiskinen T, Broberg M, Ruotsalainen S, Koskela J, Bachour A, et al. Sleep apnoea is a risk factor for severe COVID-19. BMJ Open Respir Res. 2021;8(1).","DOI":"10.1136\/bmjresp-2020-000845"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-021-09670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-021-09670-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-021-09670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T00:17:00Z","timestamp":1675556220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-021-09670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["9670"],"URL":"https:\/\/doi.org\/10.1007\/s11154-021-09670-0","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"21 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}